Clinical significance of interleukin-6 (Il-6) gene polymorphism and Il-6 serum level in pancreatic adenocarcinoma and chronic pancreatitis

Digestive Diseases and Sciences

Volumn 54, Issue 3, 2009, Pages 683-689

  Talar Wojnarowska, Renata ^a   Gasiorowska, Anita ^a   Smolarz, Beata ^b   Romanowicz Makowska, Hanna ^b   Kulig, Andrzej ^b   Malecka Panas, Ewa ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Chronic pancreatitis; Interleukin 6; Pancreatic adenocarcinoma; Polymorphism

Indexed keywords

BILIRUBIN; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; CENTRIFUGATION; CHRONIC PANCREATITIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DNA ISOLATION; DNA POLYMORPHISM; ENDOSCOPIC THERAPY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PARAMETER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STENT; TUMOR VOLUME; WEIGHT REDUCTION;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERLEUKIN-6; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PANCREAS; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 59449091742     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0390-z     Document Type: Article

References (33)

1. M Lotz 1993 Interleukin-6 Cancer Invest 11 732 742 10.3109/ 07357909309046948
2. H Ohzato K Yoshizaki N Nishimoto A Ogata H Tagoh M Monden 1992 Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery Surgery 111 201 209
3. P Damas D Ledoux M Nys Y Wrindts D De Groote P Franchimont 1992 Cytokine serum level during severe sepsis in human Il-6 as a marker of severity Ann Surg 215 356 362
4. D Fishman G Faulds R Jeffery U Mohamed-Ali JS Yudkin S Humpherces 1998 The effect of novel polymorphisms in the interleukine-6 gene on Il-6 transcription and plasma Il-6 levels and an association with systemic-onset juvenile chronic arthritis J Clin Invest 102 1369 1376 10.1172/JCI2629
5. C Dosquet A Schaetz C Faucher E Lepage JL Wautier A Richard 1994 Tumor necrosis factor-α, interleukin-1β and interleukin-6 in patients with renal cell carcinoma Eur J Cancer 30 162 167 10.1016/0959-8049(94)90079-5
6. S Okada T Okusaka H Ishii A Kyogoku M Yoshimori N Kajimura 1998 Elevated serum interleukin-6 levels in patients with pancreatic cancer Jpn J Clin Oncol 28 12 15 10.1093/jjco/28.1.12
7. CW Wu SR Wang MF Chao TC Wu 1996 Serum interleukin-6 levels reflect disease status of gastric cancer Am J Gastroenterol 91 1417 1422
8. R Lai S O'Brien T Maushouri A Rogers H Kantarijan M Keating 2002 Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia Cancer 95 1071 1075 10.1002/cncr.10772
9. K Takeda N Fujii Y Nitta H Sakihara K Nakyama H Rikishi 1991 Murine tumor cells metastasizing selectively in the liver: ability to produce hepatocyte-activating cytokines interleukin-1 and/or -6 Jpn J Cancer Res 82 1299 1308
10. SS Tabibzadeh D Poubouridis LT May PB Sehgal 1989 Interleukin-6 immunoreactivity in human tumors Am J Pathol 135 427 433
11. A DeMichele AM Martin R Mick P Gor L Wray M Klein-Cabral 2003 Interleukin-6174 G/C polymorphism is associated with improved outcome in high-risk breast cancer Cancer Res 63 8051 8056
12. N Nikiteas N Tzanakis M Gazouli G Rallis K Danilidis G Theodoropoulus 2005 Serum Il-6, TNF alpha and CRP levels in Greek colorectal cancer patients: prognosis implications World J Gastroenterol 11 1639 1643
13. AM Bowcock JR Kidd GM Lathrop L Daneshvar L May A Ray 1988 The human "interferon-beta 2/hepatocyte stimulating factor/interleukin-6" gene: DNA polymorphism studies and localization to chromosome 7p21 Genomics 3 8 16 10.1016/0888-7543(88)90152-8
14. N Haddy C Sass S Maumus B Marie S Droesch G Siest S Visvikis 2005 Biological variations, genetic polymorphisms and familial resemblance of TNF-alpha and Il-6 concentrations: STANISLAS cohort Eur J Hum Genet 13 109 117 10.1038/sj.ejhg.5201294
15. LA Hefler C Crimm S Ackermann S Malur AR Radjabi-Rahat S Leodolter 2003 An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer Cancer Res 63 3066 3068
16. C Belluco F Olivieri M Bonafe S Giovagnetti E Mammano R Scalrta 2003 174G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer Clin Cancer Res 9 2173 2176
17. MD Barber JJ Powell SF Lynch KH Fearon JA Ross 2000 A polymorphism of the interleukin-1β gene influences survival in pancreatic cancer Br J Cancer 83 1443 1447 10.1054/bjoc.2000.1479
18. B Ebrahimi SL Tucker D Li JM Abbruzzese R Kurzrock 2004 Cytokines in pancreatic carcinoma. Correlation with phenotypic characteristics and prognosis Cancer 101 2727 2736 10.1002/cncr.20672
19. Sarner M, Cotton PB (1983) Classifications of pancreatitis. International Workshop, vol 25. King's College, Cambridge, pp 756-759
20. S Landi V Moreno L Gioia-Patricola E Guino M Navarro J Oca 2003 Association of common polymorphisms in inflammatory genes interleukin (Il)-6, Il-8, tumor necrosis factor alpha, NFKB1 and peroxisome proliferator-activated receptor γ with colorectal cancer Cancer Res 63 3560 3566
21. JS Goydos AM Brumfield E Frezza A Booth MT Lotze SE Carty 1998 Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma Ann Surg 227 398 404 10.1097/00000658-199803000-00012
22. MA Bemelmans DJ Gouma JW Greve WA Burman 1992 Cytokines, tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice Hepatology 15 1132 1136 10.1002/hep. 1840150626
23. M Oka K Yamamoto M Takahashi M Hakozaki T Abe N Lizuka 1996 Relationship between serum levels of interleukin 6, various diseases parameters and malnutrition in patients with esophageal squamous cell carcinoma Cancer Res 56 2776 2780
24. JS Falconer KC Fearon CE Plester JA Ross DC Carter 1994 Cytokines, the acute-phase response and resting energy expenditure in cachectic patients with pancreatic cancer Ann Surg 219 325 331 10.1097/00000658-199404000-00001
25. T Kinoshita H Ito C Miki 1999 Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma Cancer 85 2526 2531 10.1002/(SICI)1097-0142(19990615)85:12<2526::AID-CNCR6>3.0.CO;2- 3
26. J Tanner G Tosato 1991 Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice J Clin Invest 88 239 247 10.1172/JCI115283
27. SJ Wigmore KC Fearon K Sangster JP Maingay OJ Garden JA Ross 2002 Cytokine regulation of constitutive production of interleukin-8 and -6 by human pancreatic cancer cell lines and serum cytokine concentrations in patients with pancreatic cancer Int J Oncol 21 881 886
28. A Bhatnagar JD Wig S Majumdar 2003 Immunological findings in acute and chronic pancreatitis J Surg 73 59 64
29. A Szuster-Ciesielska J Daniluk M Kandefer-Zerszen 2000 Serum levels of cytokines in alcoholic liver cirrhosis and pancreatitis Arch Immunol Ther Exp (Warsz) 48 301 307
30. T Bomba U Yoshioka H Inoue Y Iwasaki S Hosoda 1994 Serum levels of interleukin-1 beta and interleukin-6 in patients with chronic pancreatitis J Gastroenterol 29 314 319 10.1007/BF02358371
31. M Bonafe F Olivieri L Cavallone S Giovagnetti F Marchegiani M Cardelli 2001 A gender-dependent genetic predisposition to produce high levels of Il-6 is detrimental for longevity Eur J Immunol 31 2357 2361 10.1002/1521-4141(200108) 31:8<2357::AID-IMMU2357>3.0.CO;2-X
32. MT Bendicho JC Guedes NN Silva GO Santana RR Sanot AC Lyra 2005 Polymorphism of cytokine genes (TGF-beta1, INF-gamma, Il-6, Il-10 and TNF-alpha) in patients with chronic pancreatitis Pancreas 30 333 336 10.1097/01.mpa. 0000161809.24284.33
33. CB Foster T Lehrnbecher S Samuels S Stein F Mol JA Metcalf 2000 An Il-6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with immunodeficiency virus Blood 96 2562 2567